FINWIRES · TerminalLIVE
FINWIRES

HBM Holdings Unit Wins US Patent Verdict Against Amgen

By

HBM Holdings (HKG:2142) said a U.S. jury found in favor of its unit Harbour Antibodies in a patent infringement lawsuit against Amgen and its subsidiary Teneobio, according to a Monday Hong Kong bourse filing.

The jury in the U.S. District Court for the District of Delaware found that Amgen infringed a patent covering Harbour Antibodies' antibody discovery platform, that the infringement was willful, and that the patent is valid.

The jury awarded Harbour Antibodies damages of about $20.2 million, representing the full amount sought at trial.

HBM said the finding of willful infringement allows Harbour Antibodies to seek enhanced damages, which could raise the award to as much as $60.6 million if granted in full by the court.

Related Articles

Asia

Singapore Regulator to Streamline 'Single Family Office' Framework

The Monetary Authority of Singapore has revised its "single family office" (SFOs) framework to streamline the process for SFOs to establish operations in Singapore, according to a MAS release.An SFO in Singapore is a privately held corporate entity set up by one "ultra-high-net-worth" family to manage assets, investments, and wealth of a single family.The registration protocols have been simplified, effective June 15, with offices required to notify MAS of their operations through a MAS-licensed bank.Annual reporting has been made more straightforward for SFOs, with information on total assets under management and the name of its bank.

$^STI
Asia

Klevo Rewards Plans Stablecoin Trial Launch by June 30; Shares Fall 4%

Klevo Rewards (ASX:KLV) said it plans to launch a trial of its KLVAUD Australian dollar-backed stablecoin by June 30, according to a Monday filing with the Australian bourse.The company's Fly Wallet subsidiary received legal advice indicating that the stablecoin may qualify as an eligible stablecoin under the current regulatory framework, subject to conditions, per the filing.KLVAUD is planned to be fully backed one-to-one by Australian dollars held in segregated reserve accounts, and aims to support Fly Wallet's broader payments system, the company said.Klevo Rewards shares fell 4% in recent Monday trade.

$ASX:KLV
Asia

Bio-Thera Solutions Gets Europe's Results on On-Site Inspection

Bio-Thera Solutions (SHA:688177) received the results of the European Union's inspection of its Yonghe manufacturing facility, according to a Shanghai bourse filing on Monday.The French National Agency for the Safety of Medicines and Health Products conducted an inspection on the site between Feb. 4 and Feb. 12.The European Medicines Agency handed a GMP or good manufacturing practice certificate to the company after the factory's drug substance operations passed regulatory standards. However, the regulator found deficiencies in the deviation management measures for the finished formulation of the drugs.

$SHA:688177